Sign in
4

Changes in Ownership

Arcturus Therapeutics Holdings Inc. Filed Acc 0001193805-22-001002

Options or other derivatives

  • Chief Scientific Officer & COO acquired 85,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Chivukula Pad Chief Scientific Officer & COO 2022-06-21 Grant or award · Employee Stock Option (right to buy) +85,000 85,000 D: show line 1 in the form
Loading xslF345X03/e621773_4-chivukula.xml…